Cancer and microbiome: newsflash on epidemiology, fungi in etiology, and microbiome-derived markers for diagnosis
22 Mar 2023by Konstantina Zafeiropoulou
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.